Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer | Naviance

Desarrollan herramienta computacional para predecir resultados de inmunoterapia en pacientes con cáncer de mama metastásico

Utilizando herramientas computacionales, investigadores de la Centro Oncológico Johns Hopkins Kimmel y el Facultad de Medicina de la Universidad Johns Hopkins Han desarrollado un método para evaluar qué pacientes con cáncer de mama triple negativo metastásico podrían beneficiarse de la inmunoterapia.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma Treatment Resistance in Prostate Cancer Elaine’s Story: A Journey of Strength, Faith, and Healing at Johns Hopkins In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome Johns Hopkins Investigators Create New Urine-based Test to ID Prostate Cancers New therapy kickstarts immune response to cancer Prostate Cancer Treatment: What to Do When It Stops Working 5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results